Literature DB >> 8836140

Intracellular retention of a factor VIII protein with an Arg2307-->Gln mutation as a cause of haemophilia A.

J Voorberg1, R T de Laaf, P M Koster, J A van Mourik.   

Abstract

Substitution of Arg2307 by Gln in factor VIII has been found to be associated with mild to moderate haemophilia A [Gitschier, Wood, Shuman and Lawn (1986) Science 232, 1415-1416]. We have introduced this particular point mutation into a B-domain-deleted factor VIII cDNA and expressed the modified cDNA in C127 cells. Cells expressing the resulting protein, termed des-(868-1562)-factor VIII-R2307Q, were compared with those expressing the previously characterized des-(868-1562)-factor VIII. No immunoreactive material could be detected in the conditioned medium of cells transfected with des-(868-1562)-factor VIII-R2307Q cDNA using assays specific for the factor VIII light chain and the factor VIII heavy chain. Analysis of metabolically labelled cells transfected with des-(868-1562)-factor VIII-R2307Q cDNA revealed that this mutant protein is synthesized at a level similar to des-(868-1562)-factor VIII. In contrast to des-(868-1562)-factor VIII, metabolically labelled des-(868-1562)-factor VIII-R2307Q was not encountered in the conditioned medium of the transfected cells, indicating that the mutant protein is not secreted from the cell. Inspection of the intracellular localization of the two proteins in the cell employing morphological analysis, endoglycosidase H and experiments with inhibitors of glucosidases I and II was consistent with localization of des-(868-1562)-factor VIII and des-(868-1562)-factor VIII-R2307Q in the endoplasmic reticulum. Taken together, our data indicate that the Arg2307-->Gln mutation results in aberrant intracellular trafficking of factor VIII, which may explain the low levels of factor VIII antigen in the plasma of haemophilia A patients that carry this particular point mutation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836140      PMCID: PMC1217707          DOI: 10.1042/bj3180931

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

Review 1.  Structural features in eukaryotic mRNAs that modulate the initiation of translation.

Authors:  M Kozak
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

2.  Hemophilia A due to mutations that create new N-glycosylation sites.

Authors:  A M Aly; M Higuchi; C K Kasper; H H Kazazian; S E Antonarakis; L W Hoyer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  Structure of human factor VIII.

Authors:  G A Vehar; B Keyt; D Eaton; H Rodriguez; D P O'Brien; F Rotblat; H Oppermann; R Keck; W I Wood; R N Harkins; E G Tuddenham; R M Lawn; D J Capon
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

4.  Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control.

Authors:  C Hammond; I Braakman; A Helenius
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

5.  Biological activity of recombinant factor VIII variants lacking the central B-domain and the heavy-chain sequence Lys713-Arg740: discordant in vitro and in vivo activity.

Authors:  K Mertens; M J Donath; R W van Leen; M J de Keyzer-Nellen; M P Verbeet; J M Klaasse Bos; A Leyte; J A van Mourik
Journal:  Br J Haematol       Date:  1993-09       Impact factor: 6.998

6.  Sequence of the murine factor VIII cDNA.

Authors:  B Elder; D Lakich; J Gitschier
Journal:  Genomics       Date:  1993-05       Impact factor: 5.736

7.  Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII.

Authors:  P J Lenting; M J Donath; J A van Mourik; K Mertens
Journal:  J Biol Chem       Date:  1994-03-11       Impact factor: 5.157

8.  The complete cDNA sequence of bovine coagulation factor V.

Authors:  E R Guinto; C T Esmon; K G Mann; R T MacGillivray
Journal:  J Biol Chem       Date:  1992-02-15       Impact factor: 5.157

9.  Spectrum of mutations in CRM-positive and CRM-reduced hemophilia A.

Authors:  M J McGinniss; H H Kazazian; L W Hoyer; L Bi; H Inaba; S E Antonarakis
Journal:  Genomics       Date:  1993-02       Impact factor: 5.736

10.  Biogenesis of von Willebrand factor-containing organelles in heterologous transfected CV-1 cells.

Authors:  J Voorberg; R Fontijn; J Calafat; H Janssen; J A van Mourik; H Pannekoek
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  1 in total

Review 1.  Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formation.

Authors:  David W Scott; Jay N Lozier
Journal:  Br J Haematol       Date:  2011-11-07       Impact factor: 6.998

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.